BOLD
Audentes Therapeutics, Inc
BOLD
BOLD
Delisted
BOLD was delisted on the 14th of January, 2020.
147 hedge funds and large institutions have $1.69B invested in Audentes Therapeutics, Inc in 2019 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 62 increasing their positions, 34 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
1% less capital invested
Capital invested by funds: $1.71B → $1.69B (-$15.6M)
Holders
147
Holding in Top 10
8
Calls
$10.3M
Puts
$2.7M
Top Buyers
| 1 | +$51.9M | |
| 2 | +$45.4M | |
| 3 | +$17.8M | |
| 4 |
BlackRock
New York
|
+$15.7M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$13.3M |
Top Sellers
| 1 | -$41.3M | |
| 2 | -$27.7M | |
| 3 | -$15.7M | |
| 4 |
VVM
Versant Venture Management
San Francisco,
California
|
-$9.43M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$8.71M |